Empleo, Khent Lior G.
HRN: 20-09-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/17/2022
08/24/2022
IV
95mg
Q8H
Lymphadenitis Cannot Totally RO Kawasaki; PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes